60 core tissue microarray tma slide (Novus Biologicals)
Novus Biologicals is a verified supplier 
Novus Biologicals manufactures this product 
93
Structured Review
Novus Biologicals
60 core tissue microarray tma slide
60 Core Tissue Microarray Tma Slide, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+tissue+microarray/Human+Multi-tissue+Tissue+MicroArray+(Cancer)/pmc13036268-60-45-51
Average 93 stars, based on 2 article reviews
60 Core Tissue Microarray Tma Slide, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+tissue+microarray/Human+Multi-tissue+Tissue+MicroArray+(Cancer)/pmc13036268-60-45-51
Average 93 stars, based on 2 article reviews
60 core tissue microarray tma slide - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Selection:Article Title: Techniques to study chimerism at the tissue level in humanized mice Article Snippet: As described in previous works, , , rabbit antibodies targeting HLA-A (ab52922, Abcam, Cambridge, Massachusetts; IHC working dilution: 1/600) and human Ku80 (hKu80; 2180; Cell Signaling Technology, Danvers, Massachusetts; IHC working dilution: 1/100), as well as a mouse antibody against a 60 kDa protein on human mitochondria (hMito; MA5-12017; Invitrogen, Waltham, Massachusetts; IHC working dilution: 1/500), were employed as broad-spectrum immunohistochemical markers for identifying virtually all cells of human origin in chimeric mice., , While other broad-spectrum antibodies have been used for this same purpose, including NUMA-1, a comprehensive testing of all the possible markers ubiquitously expressed in human tissues was beyond the scope of this work. .. In this context, the target’s cellular location and distribution were considered in the selection, with HLA-A as a membranous antigen, hKu80 as a nuclear antigen, and hMito as a cytoplasmic marker., , , The overall sensitivity of these 3 broad-spectrum markers was investigated using a Article Title: Techniques to study chimerism at the tissue level in humanized mice. Article Snippet: As described in previous works,6,43,57 rabbit antibodies targeting HLA-A (ab52922, Abcam, Cambridge, Massachusetts; IHC working dilution: 1/600) and human Ku80 (hKu80; 2180; Cell Signaling Technology, Danvers, Massachusetts; IHC working dilution: 1/100), as well as a mouse antibody against a 60 kDa protein on human mitochondria (hMito; MA5-12017; Invitrogen, Waltham, Massachusetts; IHC working dilution: 1/500), were employed as broad-spectrum immunohistochemical markers for identifying virtually all cells of human origin in chimeric mice.9,10,13 While other broad-spectrum antibodies have been used for this same purpose, including NUMA-1,60 a comprehensive testing of all the possible markers ubiquitously expressed in human tissues was beyond the scope of this work. .. In this context, the target’s cellular location and distribution were considered in the selection, with HLA-A as a membranous antigen, hKu80 as a nuclear antigen, and hMito as a cytoplasmic marker.2,6,12,44 The overall sensitivity of these 3 broad-spectrum markers was investigated using a Marker:Article Title: Techniques to study chimerism at the tissue level in humanized mice Article Snippet: As described in previous works, , , rabbit antibodies targeting HLA-A (ab52922, Abcam, Cambridge, Massachusetts; IHC working dilution: 1/600) and human Ku80 (hKu80; 2180; Cell Signaling Technology, Danvers, Massachusetts; IHC working dilution: 1/100), as well as a mouse antibody against a 60 kDa protein on human mitochondria (hMito; MA5-12017; Invitrogen, Waltham, Massachusetts; IHC working dilution: 1/500), were employed as broad-spectrum immunohistochemical markers for identifying virtually all cells of human origin in chimeric mice., , While other broad-spectrum antibodies have been used for this same purpose, including NUMA-1, a comprehensive testing of all the possible markers ubiquitously expressed in human tissues was beyond the scope of this work. .. In this context, the target’s cellular location and distribution were considered in the selection, with HLA-A as a membranous antigen, hKu80 as a nuclear antigen, and hMito as a cytoplasmic marker., , , The overall sensitivity of these 3 broad-spectrum markers was investigated using a Article Title: Techniques to study chimerism at the tissue level in humanized mice. Article Snippet: As described in previous works,6,43,57 rabbit antibodies targeting HLA-A (ab52922, Abcam, Cambridge, Massachusetts; IHC working dilution: 1/600) and human Ku80 (hKu80; 2180; Cell Signaling Technology, Danvers, Massachusetts; IHC working dilution: 1/100), as well as a mouse antibody against a 60 kDa protein on human mitochondria (hMito; MA5-12017; Invitrogen, Waltham, Massachusetts; IHC working dilution: 1/500), were employed as broad-spectrum immunohistochemical markers for identifying virtually all cells of human origin in chimeric mice.9,10,13 While other broad-spectrum antibodies have been used for this same purpose, including NUMA-1,60 a comprehensive testing of all the possible markers ubiquitously expressed in human tissues was beyond the scope of this work. .. In this context, the target’s cellular location and distribution were considered in the selection, with HLA-A as a membranous antigen, hKu80 as a nuclear antigen, and hMito as a cytoplasmic marker.2,6,12,44 The overall sensitivity of these 3 broad-spectrum markers was investigated using a Microarray:Article Title: Techniques to study chimerism at the tissue level in humanized mice Article Snippet: As described in previous works, , , rabbit antibodies targeting HLA-A (ab52922, Abcam, Cambridge, Massachusetts; IHC working dilution: 1/600) and human Ku80 (hKu80; 2180; Cell Signaling Technology, Danvers, Massachusetts; IHC working dilution: 1/100), as well as a mouse antibody against a 60 kDa protein on human mitochondria (hMito; MA5-12017; Invitrogen, Waltham, Massachusetts; IHC working dilution: 1/500), were employed as broad-spectrum immunohistochemical markers for identifying virtually all cells of human origin in chimeric mice., , While other broad-spectrum antibodies have been used for this same purpose, including NUMA-1, a comprehensive testing of all the possible markers ubiquitously expressed in human tissues was beyond the scope of this work. .. In this context, the target’s cellular location and distribution were considered in the selection, with HLA-A as a membranous antigen, hKu80 as a nuclear antigen, and hMito as a cytoplasmic marker., , , The overall sensitivity of these 3 broad-spectrum markers was investigated using a Article Title: Techniques to study chimerism at the tissue level in humanized mice. Article Snippet: As described in previous works,6,43,57 rabbit antibodies targeting HLA-A (ab52922, Abcam, Cambridge, Massachusetts; IHC working dilution: 1/600) and human Ku80 (hKu80; 2180; Cell Signaling Technology, Danvers, Massachusetts; IHC working dilution: 1/100), as well as a mouse antibody against a 60 kDa protein on human mitochondria (hMito; MA5-12017; Invitrogen, Waltham, Massachusetts; IHC working dilution: 1/500), were employed as broad-spectrum immunohistochemical markers for identifying virtually all cells of human origin in chimeric mice.9,10,13 While other broad-spectrum antibodies have been used for this same purpose, including NUMA-1,60 a comprehensive testing of all the possible markers ubiquitously expressed in human tissues was beyond the scope of this work. .. In this context, the target’s cellular location and distribution were considered in the selection, with HLA-A as a membranous antigen, hKu80 as a nuclear antigen, and hMito as a cytoplasmic marker.2,6,12,44 The overall sensitivity of these 3 broad-spectrum markers was investigated using a other:Article Title: MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways. Article Snippet: The inhibitors of BRAF and MEK targeting MAPK signaling pathway provide a comparatively effective therapeutic strategy for melanoma caused by BRAF mutation.. However, melanoma, especially metastatic melanoma, has become one of the most threatening malignancies.. Thus, the identification of exact molecular mechanisms and the key components involved in such mechanisms is urgently needed in order to provide new therapeutic options for patients with melanoma. |